S.S. Ramalingam

Identification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate Cancer

Nitya V. Sharma, Kathryn L. Pellegrini, Véronique Ouellet et al. · Cancers · 2018 · 43 citations · Full text

3083 AZD9291 activity in patients with EGFR-mutant advanced non-small cell lung cancer (NSCLC) and brain metastases: Data from Phase II studies

M.-J. Ahn, C.M. Tsai, J.C-H. Yang et al. · European Journal of Cancer · 2015 · 42 citations

Brain Metastases, Pathology, Azd9291 Activity +8

Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial

Hossein Borghaei, Kenneth J. O’Byrne, Luis Paz‐Ares et al. · ESMO Open · 2023 · 41 citations · Full text

Mechanisms of acquired resistance to first-line osimertinib: Preliminary data from the phase III FLAURA study

Byoung Chul Cho, Y. Cheng, Changdong Zhou et al. · Annals of Oncology · 2018 · 40 citations · Full text

Biology, Physiology, Preliminary Data +1

Nivolumab (NIVO) + low-dose ipilimumab (IPI) vs platinum-doublet chemotherapy (chemo) as first-line (1L) treatment (tx) for advanced non-small cell lung cancer (NSCLC): CheckMate 227 part 1 final analysis

Solange Peters, S.S. Ramalingam, Luis Paz‐Ares et al. · Annals of Oncology · 2019 · 32 citations · Full text

Part 1, Oncology, Low-dose Ipilimumab +7